Page last updated: 2024-09-04

mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and adenine

mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with adenine in 1 studies

Compound Research Comparison

Studies
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)
Trials
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)
Recent Studies (post-2010)
(mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin)
Studies
(adenine)
Trials
(adenine)
Recent Studies (post-2010) (adenine)
6904221,9031,1537,682

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, Y; Dai, XY; Guan, QC; Guan, Y; Kong, W; Wang, X; Xu, MJ; Zhao, MM; Zhao, Y; Zhu, WG1

Other Studies

1 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and adenine

ArticleYear
Phosphate-induced autophagy counteracts vascular calcification by reducing matrix vesicle release.
    Kidney international, 2013, Volume: 83, Issue:6

    Topics: Adenine; Alkaline Phosphatase; Amino Acid Chloromethyl Ketones; Animals; Antioxidants; Autophagy; Autophagy-Related Protein 5; Caspase Inhibitors; Cattle; Cells, Cultured; Disease Models, Animal; Kidney Failure, Chronic; Metalloporphyrins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Phosphates; Proteins; Rats; RNA Interference; Secretory Vesicles; Sodium-Phosphate Cotransporter Proteins, Type III; Superoxide Dismutase; Time Factors; Transfection; Valproic Acid; Vascular Calcification

2013